Literature DB >> 3926027

Polyamines and estrogen control of growth of the NMU-induced rat mammary tumor.

A Manni, C Wright, M Pontari.   

Abstract

Recent in vitro evidence suggests that polyamines play an important role in the growth of the N-nitrosomethyl-urea (NMU)-induced rat mammary tumor, and that they may be involved in mediating the effect of estrogens on tumor growth. In support of this hypothesis, we here show that inhibition of polyamine biosynthesis with alpha-difluoromethyl-ornithine (DFMO) blocks the mitogenic effect of estradiol-17 beta (E2) added to NMU-mammary tumors grown in soft agar in the presence of the antiestrogen tamoxifen (Tam). Exogenous polyamine administration reversed the inhibitory effect of DFMO and restored E2 action. Administration of polyamine inhibitors to NMU-tumor-bearing rats induced significant inhibition of tumor growth, although tumor ornithine decarboxylase (ODC) was not consistently suppressed. Under our experimental conditions, such treatment did not potentiate the antitumor effect of Tam. Tam alone was found to suppress tumor ODC, suggesting a possible involvement of the polyamine pathway in its antitumor action. These data suggest that the polyamines may play an important role in the hormonal control of the growth of this experimental breast cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3926027     DOI: 10.1007/bf01805986

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  20 in total

Review 1.  Polyamines in rapid growth and cancer.

Authors:  J Jänne; H Pösö; A Raina
Journal:  Biochim Biophys Acta       Date:  1978-04-06

2.  Methyl glyoxal bis(guanylhydrazone) as a potent inhibitor of mammalian and yeast S-adenosylmethionine decarboxylases.

Authors:  H G Williams-Ashman; A Schenone
Journal:  Biochem Biophys Res Commun       Date:  1972-01-14       Impact factor: 3.575

3.  The generality of methylglyoxal bis(guanylhydrazone)-induced mitochondrial damage and the dependence of this effect on cell proliferation.

Authors:  F Mikles-Robertson; B Feuerstein; C Dave; C W Porter
Journal:  Cancer Res       Date:  1979-06       Impact factor: 12.701

4.  Polyamine synthesis and accumulation in the castrated rat uterus after estradiol-17-beta stimulation.

Authors:  D H Russell; R L Taylor
Journal:  Endocrinology       Date:  1971-06       Impact factor: 4.736

5.  Depletion of 9L rat brain tumor cell polyamine content by treatment with D,L-alpha-difluoromethylornithine inhibits proliferation and the G1 to S transition.

Authors:  J Seidenfeld; J W Gray; L J Marton
Journal:  Exp Cell Res       Date:  1981-01       Impact factor: 3.905

Review 6.  Use of polyamine antimetabolites in experimental tumours and in human leukemia.

Authors:  J Jänne; L Alhonen-Hongisto; P Seppänen; M Siimes
Journal:  Med Biol       Date:  1981-12

7.  Antitumor effect of dicyclohexylammonium sulfate, a potent inhibitor of spermidine synthase against P388 leukemia.

Authors:  H Ito; H Hibasami; K Shimura; J Nagai; H Hidaka
Journal:  Cancer Lett       Date:  1982 Mar-Apr       Impact factor: 8.679

8.  Reversal of the antiproliferative effect of the antiestrogen tamoxifen by polyamines in breast cancer cells.

Authors:  A Manni; C Wright
Journal:  Endocrinology       Date:  1984-03       Impact factor: 4.736

9.  Direct cloning of human neuroblastoma cells in soft agar culture.

Authors:  D D Von Hoff; J Casper; E Bradley; J M Trent; A Hodach; C Reichert; R Makuch; A Altman
Journal:  Cancer Res       Date:  1980-10       Impact factor: 12.701

10.  FSH and LH stimulation of ornithine decarboxylase activity: studies with porcine granulosa cells in vitro.

Authors:  J Osterman; J M Hammond
Journal:  Endocrinology       Date:  1977-10       Impact factor: 4.736

View more
  1 in total

1.  Role of polyamines in the growth of hormone-responsive experimental breast cancer in vivo.

Authors:  A Manni; B Badger; G Luk; C Wright; R Caplan; H Rockette; M Bartholomew; S R Ahmed
Journal:  Breast Cancer Res Treat       Date:  1988-07       Impact factor: 4.872

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.